%20(2).png){kind=logo}
TrumpRx may reshape U.S. drug access—Pfizer leads the way as experts weigh cost savings, transparency, and the impact on patients, insurers, and pharma.
Verily’s ex-chief commercial officer sued the healthtech company for wrongful employment, citing HIPAA violations.
The U.S. will impose 100% tariffs on imported branded drugs from Oct. 1, 2025, exempting firms with U.S. projects. Pharma must localize, pursue deals, and manage unclear exemption rules.
The unified digital platform helps providers and patients access clear, compliant, and personalized pharmaceutical information with AI-powered tools.
The FDA has launched a two-pronged crackdown on drug ads, sending mass warnings to thousands of companies and secret cease-and-desist orders to 100 targeting specific promotions.
Ostro Health unveils a new engagement play, connecting pharma to HCPs faster.
Ostro's Airmark enables compliant, AI-driven conversations in pharma emails, boosting HCP engagement and system integration.
.svg)